Abstract:Intra-abdominal infections (IAIs) account for a major cause of morbidity and mortality, representing the second most common sepsis-related death with a hospital mortality of 23-38%. Prompt identification of sepsis source, appropriate resuscitation, and early treatment with the shortest delay possible are the cornerstones of management of IAIs and are associated with a more favorable clinical outcome. The aim of source control is to reduce microbial load by removing the infection source and it is achievable by using a wide range of procedures, such as definitive surgical removal of anatomic infectious foci, percutaneous drainage and toilette of infected collections, decompression, and debridement of infected and necrotic tissue or device removal, providing for the restoration of anatomy and function. Damage control surgery may be an option in selected septic patients. Intra-abdominal infections can be classified as uncomplicated or complicated causing localized or diffuse peritonitis. Early clinical evaluation is mandatory in order to optimize diagnostic testing and establish a therapeutic plan. Prognostic scores could serve as helpful tools in medical settings for evaluating both the seriousness and future outlook of a condition. The patient's conditions and the potential progression of the disease determine when to initiate source control. Patients can be classified into three groups based on disease severity, the origin of infection, and the patient's overall physical health, as well as any existing comorbidities. In recent decades, antibiotic resistance has become a global health threat caused by inappropriate antibiotic regimens, inadequate control measures, and infection prevention. The sepsis prevention and infection control protocols combined with optimizing antibiotic administration are crucial to improve outcome and should be encouraged in surgical departments. Antibiotic and antifungal regimens in patients with IAIs should be based on the resistance epidemiology, clinical conditions, and risk for multidrug resistance (MDR) and Candida spp. infections. Several challenges still exist regarding the effectiveness, timing, and patient stratification, as well as the procedures for source control. Antibiotic choice, optimal dosing, and duration of therapy are essential to achieve the best treatment. Promoting standard of care in the management of IAIs improves clinical outcomes worldwide. Further trials and stronger evidence are required to achieve optimal management with the least morbidity in the clinical care of critically ill patients with intra-abdominal sepsis.

Strategy of diagnosis and management of intra-abdominal infection after gastrointestinal surgery

Investigation of treatment and analysis of prognostic risk on intra-abdominal fistula in China: a multicenter prospective study

The predictive factors for postoperative intra-abdominal septic complications after intestinal resection in patients with Crohn's Disease

Distribution of pathogens and changes of cytokines in peripheral blood of patients after abdominal surgery

Current Problems and Strategies in the Management of Intra-Abdominal Infection

Current Progress of Source Control in the Management of Intra-Abdominal Infections

Treatment Experience of Severe Abdominal Infection after Orthotopic Liver Transplantation

Source Control and Antibiotics in Intra-Abdominal Infections

Progress in treatment of intra-abdominal infection caused by abdominal trauma

[Progress in the treatment of intra-abdominal anaerobic infection]

Step-up Approach of Source Control for Intra-abdominal Infection

Open Abdomen Management for Severe Intraabdominal Infection

Decision Making in the Source Control of Intra-Abdominal Infection

Intra-abdominal infections survival guide: a position statement by the Global Alliance For Infections In Surgery

Perioperative complicated intra-abdominal infections:Recognition and standardized therapy

Current Status of the Open Abdomen Treatment for Intra-Abdominal Infection.

Diagnosis and Management of Intraabdominal Infection: Guidelines by the Chinese Society of Surgical Infection and Intensive Care and the Chinese College of Gastrointestinal Fistula Surgeons

Antimicrobial Therapy for Intra-Abdominal Infections: Guidelines from the Infectious Disease Advisory Board (IDAB)

[Analysis of the Risk Factors Related to Prognosis of Severe Intra-Abdominal Infection in Surgical Intensive Care Unit].

Microbiology of Pathogenic Bacteria with Abdominal Surgical Emergency

[Current Practice in the Prevention and Management of Surgical Site Infections in Gastrointestinal Surgery].